CompletedNCT00391222
Risperidone for Bipolarity
This study is completed in China, in Colombia, in Germany, .... It is testing risperidone for Bipolarity.
BipolarityOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02969382
SEP-363856 for schizophrenia
This study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 40 Years
CompletedNCT01364662
SPN-810 for ADHD
This study is completed in the United States. It is testing SPN-810 for ADHD.
ADHDOtherFrom 6 Years to 12 Years
CompletedNCT00531752
Two Doses of PF-03654746 for ADHD
This study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.
ADHDOtherFrom 18 Years to 55 Years
CompletedNCT01725308
Efficacy of FK949E in Bipolarity people with Major Depressive Episodes
This study is completed in Japan. It is testing Efficacy of FK949E for depression.
Bipolarity, DepressionOtherFrom 20 Years to 64 Years
UnknownNCT06399523
Efficacy of VR for Bipolarity
This study has public registry information in China. It is testing Efficacy of VR for Bipolarity.
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 13 Years
UnknownNCT06359899
Safety study of AK0901 in ADHD
This study has public registry information in China. It is testing AK0901 for ADHD.
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
CompletedNCT02969369
Safety study of SEP-363856 in Schizophrenia
This study is completed in the United States. It is testing SEP-363856 for Schizophrenia.
SchizophreniaOtherFrom 55 Years to 105 Years
CompletedNCT06136936
Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia
This study is completed in the United States. It is testing Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia.
SchizophreniaOtherOver 18 Years
CompletedNCT01206517
Safety study of sublingual Asenapine in schizophrenia
This study is completed in Global. It is testing sublingual Asenapine for schizophrenia.
Bipolarity, SchizophreniaOtherFrom 10 Years to 17 Years
CompletedNCT06024239
Safety study of Pharmacokinetics, Safety, and Tolerability of ABBV-932 in anxiety
This study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
Bipolarity, AnxietyOtherFrom 18 Years to 65 Years
CompletedNCT03745820
Safety study of Safety and Efficacy of BIIB104 in schizophrenia
This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years